Update on interleukin-2.
Shelton
B K
BK
D002292:Carcinoma, Renal Cell / Q000556:secondary* / Q000628:therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D007376:Interleukin-2